Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Oncolytic Virus Immunotherapy industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Sorrento Therapeutics
Oncorus
Merck
TILT Biotherapeutics
Shanghai Sunway Biotech
Amgen
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Engineering Oncolytic Viruses
Wild-Type Oncolytic Viruses
Application:
Hospitals
Clinics
Ambulatory Surgical Centers
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Oncolytic Virus Immunotherapy Industry Overview
-
1.1.1 Oncolytic Virus Immunotherapy Market Scope and Market Segments
-
1.1.2 Oncolytic Virus Immunotherapy Industry Characteristics
-
1.1.3 Global and China Oncolytic Virus Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Oncolytic Virus Immunotherapy Production Value and Growth Rate (2017-2028)
-
1.2 Global Oncolytic Virus Immunotherapy Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Engineering Oncolytic Viruses
-
1.2.2 Wild-Type Oncolytic Viruses
-
1.3 Global Oncolytic Virus Immunotherapy Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Hospitals
-
1.3.2 Clinics
-
1.3.3 Ambulatory Surgical Centers
-
1.4 Market Analysis by Region
-
1.4.1 North America Oncolytic Virus Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Oncolytic Virus Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Oncolytic Virus Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Oncolytic Virus Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Oncolytic Virus Immunotherapy Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Oncolytic Virus Immunotherapy Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Oncolytic Virus Immunotherapy Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Oncolytic Virus Immunotherapy Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Oncolytic Virus Immunotherapy Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Oncolytic Virus Immunotherapy Industry Porter's Five Forces Model Analysis
-
2.2.3 Oncolytic Virus Immunotherapy Industry PEST Analysis
-
2.3 Oncolytic Virus Immunotherapy Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Oncolytic Virus Immunotherapy Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Oncolytic Virus Immunotherapy Industry
Chapter 3 Global and China Oncolytic Virus Immunotherapy Market, by Manufacturer
-
3.1 Global and China Oncolytic Virus Immunotherapy Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Oncolytic Virus Immunotherapy Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Oncolytic Virus Immunotherapy Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Oncolytic Virus Immunotherapy Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Oncolytic Virus Immunotherapy Market Top 3 Players
Chapter 4 Global and China Oncolytic Virus Immunotherapy Market, by Type (2017-2028)
-
4.1 Oncolytic Virus Immunotherapy Market Trend, by Type
-
4.2 Global Oncolytic Virus Immunotherapy Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Oncolytic Virus Immunotherapy Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Oncolytic Virus Immunotherapy Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Oncolytic Virus Immunotherapy Price Trend, by Type (2017-2028)
-
4.3 China Oncolytic Virus Immunotherapy Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Oncolytic Virus Immunotherapy Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Oncolytic Virus Immunotherapy Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Oncolytic Virus Immunotherapy Price Trend, by Type (2017-2028)
Chapter 5 Global and China Oncolytic Virus Immunotherapy Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Oncolytic Virus Immunotherapy Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Oncolytic Virus Immunotherapy Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Oncolytic Virus Immunotherapy Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Oncolytic Virus Immunotherapy Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Oncolytic Virus Immunotherapy Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Oncolytic Virus Immunotherapy Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Oncolytic Virus Immunotherapy Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Oncolytic Virus Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Oncolytic Virus Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Oncolytic Virus Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Oncolytic Virus Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Oncolytic Virus Immunotherapy Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Oncolytic Virus Immunotherapy Market Analysis
-
7.1 North America Oncolytic Virus Immunotherapy Market, by Type
-
7.2 North America Oncolytic Virus Immunotherapy Market, by Application
-
7.3 North America Oncolytic Virus Immunotherapy Market Analysis and Forecast, by Country
-
7.3.1 United States Oncolytic Virus Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Oncolytic Virus Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Oncolytic Virus Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Oncolytic Virus Immunotherapy Market Analysis
-
8.1 Europe Oncolytic Virus Immunotherapy Market, by Type
-
8.2 Europe Oncolytic Virus Immunotherapy Market, by Application
-
8.3 Europe Oncolytic Virus Immunotherapy Market Analysis and Forecast, by Country
-
8.3.1 Germany Oncolytic Virus Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Oncolytic Virus Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Oncolytic Virus Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Oncolytic Virus Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Oncolytic Virus Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Oncolytic Virus Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Oncolytic Virus Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Oncolytic Virus Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Oncolytic Virus Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Oncolytic Virus Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Oncolytic Virus Immunotherapy Market Analysis
-
9.1 APAC Oncolytic Virus Immunotherapy Market, by Type
-
9.2 APAC Oncolytic Virus Immunotherapy Market, by Application
-
9.3 APAC Oncolytic Virus Immunotherapy Market Analysis and Forecast, by Country
-
9.3.1 China Oncolytic Virus Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Oncolytic Virus Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Oncolytic Virus Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Oncolytic Virus Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Oncolytic Virus Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Oncolytic Virus Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Oncolytic Virus Immunotherapy Market Analysis
-
10.1 Latin America, Middle East and Africa Oncolytic Virus Immunotherapy Market, by Type
-
10.2 Latin America, Middle East and Africa Oncolytic Virus Immunotherapy Market, by Application
-
10.3 Latin America, Middle East and Africa Oncolytic Virus Immunotherapy Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Oncolytic Virus Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Oncolytic Virus Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Oncolytic Virus Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Oncolytic Virus Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Oncolytic Virus Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Oncolytic Virus Immunotherapy Company Profiles
-
11.1 Sorrento Therapeutics
-
11.1.1 Sorrento Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Sorrento Therapeutics Oncolytic Virus Immunotherapy Product Profiles, Application and Specification
-
11.1.3 Sorrento Therapeutics Oncolytic Virus Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Oncorus
-
11.2.1 Oncorus Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Oncorus Oncolytic Virus Immunotherapy Product Profiles, Application and Specification
-
11.2.3 Oncorus Oncolytic Virus Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Merck
-
11.3.1 Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Merck Oncolytic Virus Immunotherapy Product Profiles, Application and Specification
-
11.3.3 Merck Oncolytic Virus Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 TILT Biotherapeutics
-
11.4.1 TILT Biotherapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 TILT Biotherapeutics Oncolytic Virus Immunotherapy Product Profiles, Application and Specification
-
11.4.3 TILT Biotherapeutics Oncolytic Virus Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Shanghai Sunway Biotech
-
11.5.1 Shanghai Sunway Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Product Profiles, Application and Specification
-
11.5.3 Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Amgen
-
11.6.1 Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Amgen Oncolytic Virus Immunotherapy Product Profiles, Application and Specification
-
11.6.3 Amgen Oncolytic Virus Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Oncolytic Virus Immunotherapy Industry Investment Prospect and Risk Assessment
-
12.1 Oncolytic Virus Immunotherapy Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Oncolytic Virus Immunotherapy Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Oncolytic Virus Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure China Oncolytic Virus Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Global Oncolytic Virus Immunotherapy Production Value and Growth Rate (2017-2028)
-
Figure China Oncolytic Virus Immunotherapy Production Value and Growth Rate (2017-2028)
-
Figure Global Oncolytic Virus Immunotherapy Market Size and Growth Rate of Engineering Oncolytic Viruses (2017-2028)
-
Figure Global Oncolytic Virus Immunotherapy Market Size and Growth Rate of Wild-Type Oncolytic Viruses (2017-2028)
-
Figure Global Oncolytic Virus Immunotherapy Market Size and Growth Rate of Hospitals (2017-2028)
-
Figure Global Oncolytic Virus Immunotherapy Market Size and Growth Rate of Clinics (2017-2028)
-
Figure Global Oncolytic Virus Immunotherapy Market Size and Growth Rate of Ambulatory Surgical Centers (2017-2028)
-
Figure North America Oncolytic Virus Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Oncolytic Virus Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Oncolytic Virus Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Oncolytic Virus Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Oncolytic Virus Immunotherapy Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Oncolytic Virus Immunotherapy Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Oncolytic Virus Immunotherapy Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Oncolytic Virus Immunotherapy Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Oncolytic Virus Immunotherapy Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Oncolytic Virus Immunotherapy Market Share, by Manufacturer in 2021
-
Figure Global and China Oncolytic Virus Immunotherapy Market Share, by Manufacturer in 2022
-
Table Global Oncolytic Virus Immunotherapy Sales Volume, by Type (2017-2028)
-
Table Global Oncolytic Virus Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Figure Global Oncolytic Virus Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Table Global Oncolytic Virus Immunotherapy Sales Value, by Type (2017-2028)
-
Table Global Oncolytic Virus Immunotherapy Sales Value Share, by Type (2017-2028)
-
Figure Global Oncolytic Virus Immunotherapy Price Trend, by Type (2017-2028)
-
Table China Oncolytic Virus Immunotherapy Sales Volume, by Type (2017-2028)
-
Table China Oncolytic Virus Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Figure China Oncolytic Virus Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Table China Oncolytic Virus Immunotherapy Sales Value, by Type (2017-2028)
-
Table China Oncolytic Virus Immunotherapy Sales Value Share, by Type (2017-2028)
-
Figure China Oncolytic Virus Immunotherapy Price Trend, by Type (2017-2028)
-
Table Global Oncolytic Virus Immunotherapy Sales Volume, by Application (2017-2028)
-
Table Global Oncolytic Virus Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure Global Oncolytic Virus Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Table Global Oncolytic Virus Immunotherapy Sales Value, by Application (2017-2028)
-
Table Global Oncolytic Virus Immunotherapy Sales Value Share, by Application (2017-2028)
-
Figure Global Oncolytic Virus Immunotherapy Sales Value Share, by Application (2017-2028)
-
Table China Oncolytic Virus Immunotherapy Sales Volume, by Application (2017-2028)
-
Table China Oncolytic Virus Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure China Oncolytic Virus Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Table China Oncolytic Virus Immunotherapy Sales Value, by Application (2017-2028)
-
Table China Oncolytic Virus Immunotherapy Sales Value Share, by Application (2017-2028)
-
Figure China Oncolytic Virus Immunotherapy Sales Value Share, by Application (2017-2028)
-
Figure China Oncolytic Virus Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
Figure North America Oncolytic Virus Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Oncolytic Virus Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Oncolytic Virus Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Oncolytic Virus Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
Table North America Oncolytic Virus Immunotherapy Sales Volume, by Type (2017-2028)
-
Table North America Oncolytic Virus Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Figure North America Oncolytic Virus Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Table North America Oncolytic Virus Immunotherapy Sales Volume, by Application (2017-2028)
-
Table North America Oncolytic Virus Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure North America Oncolytic Virus Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure United States Oncolytic Virus Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure United States Oncolytic Virus Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Canada Oncolytic Virus Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Oncolytic Virus Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Oncolytic Virus Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Oncolytic Virus Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Table Europe Oncolytic Virus Immunotherapy Sales Volume, by Type (2017-2028)
-
Table Europe Oncolytic Virus Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Figure Europe Oncolytic Virus Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Table Europe Oncolytic Virus Immunotherapy Sales Volume, by Application (2017-2028)
-
Table Europe Oncolytic Virus Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure Europe Oncolytic Virus Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure Germany Oncolytic Virus Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Oncolytic Virus Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure UK Oncolytic Virus Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure UK Oncolytic Virus Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure France Oncolytic Virus Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure France Oncolytic Virus Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Italy Oncolytic Virus Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Oncolytic Virus Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Oncolytic Virus Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Oncolytic Virus Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Spain Oncolytic Virus Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Oncolytic Virus Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Oncolytic Virus Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Oncolytic Virus Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Poland Oncolytic Virus Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Oncolytic Virus Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Russia Oncolytic Virus Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Oncolytic Virus Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Oncolytic Virus Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Oncolytic Virus Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Table APAC Oncolytic Virus Immunotherapy Sales Volume, by Type (2017-2028)
-
Table APAC Oncolytic Virus Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Figure APAC Oncolytic Virus Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Table APAC Oncolytic Virus Immunotherapy Sales Volume, by Application (2017-2028)
-
Table APAC Oncolytic Virus Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure APAC Oncolytic Virus Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure China Oncolytic Virus Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure China Oncolytic Virus Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Japan Oncolytic Virus Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Oncolytic Virus Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Oncolytic Virus Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Oncolytic Virus Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure India Oncolytic Virus Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure India Oncolytic Virus Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Oncolytic Virus Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Oncolytic Virus Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Oncolytic Virus Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Oncolytic Virus Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Oncolytic Virus Immunotherapy Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Oncolytic Virus Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Oncolytic Virus Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Oncolytic Virus Immunotherapy Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Oncolytic Virus Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Oncolytic Virus Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Oncolytic Virus Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Oncolytic Virus Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Oncolytic Virus Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Oncolytic Virus Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Oncolytic Virus Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Oncolytic Virus Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Oncolytic Virus Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Oncolytic Virus Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Oncolytic Virus Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Oncolytic Virus Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Table Sorrento Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sorrento Therapeutics Product Profiles, Application and Specification
-
Table Sorrento Therapeutics Oncolytic Virus Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Oncorus Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Oncorus Product Profiles, Application and Specification
-
Table Oncorus Oncolytic Virus Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Merck Product Profiles, Application and Specification
-
Table Merck Oncolytic Virus Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table TILT Biotherapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table TILT Biotherapeutics Product Profiles, Application and Specification
-
Table TILT Biotherapeutics Oncolytic Virus Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Shanghai Sunway Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Shanghai Sunway Biotech Product Profiles, Application and Specification
-
Table Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Amgen Product Profiles, Application and Specification
-
Table Amgen Oncolytic Virus Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
